Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'

Detalles Bibliográficos
Autores principales: Willemse, P M, Burggraaf, J, Hamdy, N A T, Osanto, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Reply to Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817323/
https://www.ncbi.nlm.nih.gov/pubmed/24045664
http://dx.doi.org/10.1038/bjc.2013.567
_version_ 1782478055690731520
author Willemse, P M
Burggraaf, J
Hamdy, N A T
Osanto, S
author_facet Willemse, P M
Burggraaf, J
Hamdy, N A T
Osanto, S
author_sort Willemse, P M
collection PubMed
description
format Online
Article
Text
id pubmed-3817323
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-38173232013-11-06 Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors' Willemse, P M Burggraaf, J Hamdy, N A T Osanto, S Br J Cancer Reply to Letter to the Editor Nature Publishing Group 2013-10-29 2013-09-17 /pmc/articles/PMC3817323/ /pubmed/24045664 http://dx.doi.org/10.1038/bjc.2013.567 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Reply to Letter to the Editor
Willemse, P M
Burggraaf, J
Hamdy, N A T
Osanto, S
Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
title Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
title_full Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
title_fullStr Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
title_full_unstemmed Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
title_short Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
title_sort reply: ‘comment on prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
topic Reply to Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817323/
https://www.ncbi.nlm.nih.gov/pubmed/24045664
http://dx.doi.org/10.1038/bjc.2013.567
work_keys_str_mv AT willemsepm replycommentonprevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors
AT burggraafj replycommentonprevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors
AT hamdynat replycommentonprevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors
AT osantos replycommentonprevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors

Ejemplares similares